1. Home
  2. SLE vs GTBP Comparison

SLE vs GTBP Comparison

Compare SLE & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Super League Enterprise Inc.

SLE

Super League Enterprise Inc.

HOLD

Current Price

$4.53

Market Cap

177.4M

ML Signal

HOLD

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

N/A

Current Price

$5.98

Market Cap

13.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLE
GTBP
Founded
2014
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
177.4M
13.0M
IPO Year
2019
2016

Fundamental Metrics

Financial Performance
Metric
SLE
GTBP
Price
$4.53
$5.98
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$60.00
N/A
AVG Volume (30 Days)
2.1M
415.5K
Earning Date
05-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.75
EPS
N/A
N/A
Revenue
$2,064,000.00
N/A
Revenue This Year
$24.86
N/A
Revenue Next Year
$49.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
90.41
N/A
52 Week Low
$0.48
$0.22
52 Week High
$11.43
$5.95

Technical Indicators

Market Signals
Indicator
SLE
GTBP
Relative Strength Index (RSI) 60.30 98.19
Support Level $2.66 $0.39
Resistance Level $5.24 N/A
Average True Range (ATR) 0.48 0.17
MACD 0.04 0.55
Stochastic Oscillator 67.66 95.76

Price Performance

Historical Comparison
SLE
GTBP

About SLE Super League Enterprise Inc.

Super League Enterprise Inc connects brands with the gaming population of around 3.5 billion through advertising and branded content programs across gaming and digital media platforms. The Company generates revenue by delivering these programs through proprietary interactive formats, creator content, immersive experiences, data-driven insights, and strategic campaign services designed to improve marketing performance. By translating player behavior into actionable intelligence, Super League serves as a trusted partner helping brands reach and influence consumers who play video games. With a deep understanding of this engaged yet under-monetized audience, it is positioned to capture an increasing share of brand advertising spend as the market evolves.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: